7/31/2023CDE Announces Office Relocation and Related Matters

7/28/2023CDE Solicits Comments on Technical Guidance for Clinical Pharmacologic...

7/27/2023CDE Solicits Comments on Bioequivalence Study Guidelines of Five Gener...

7/27/2023CDE Issues on Three Guideline Documents on Patient-centered Clinical R...

7/27/2023CDE Issues on the Guidelines for the Study of Disease Natural History ...

7/25/2023CDE Solicits Comments on the Technical Guidelines for Clinical Applica...

7/25/2023CDE Solicits Comments on the Technical Guidelines for Clinically Relev...

7/25/2023CDE Issues the Technical Guidelines for Preparation and Research of Ne...

7/24/2023NHC Launches One-Year Campaign to Crackdown on Corruption in Pharmaceu...

7/24/2023CDE Solicits Comments on the Technical Guidelines for Radiolabeled Hum...

7/21/2023US Congressional Panel Raises Concerns Over 'Inadequate' FDA Inspectio...

7/21/2023NMPA Holds the 2023 National Drug Regulatory Work Symposium

7/21/2023NMPA Issues Notice on Revision of Certain Articles of the Provisions f...

7/18/2023NDRC Releases the Draft Industrial Structure Adjustment Guidance Catal...

7/17/2023NMPA Solicits Comments on the Technical Guidelines for Clinical Resear...

7/17/2023NMPA Issues the List of Reference Formulations for GQCE Studies (70th ...

7/17/2023NMPA Announces Additional Professional Journal Approved for Rx Drug Ad...

7/14/2023Snapshot of Import Drugs Approved by NMPA in 2022 (2)

7/11/2023NMPA Issues the Technical Guidelines for Clinical Trials of Human Papi...

7/10/2023NMPA Solicits Comments on the CDE Work Procedures for Safety Informati...

7/10/2023CDE Issues the Principles for the Identification, Management, and Eval...

7/5/2023NMPA and Chinese Customs Announce the Customs Commodity Codes of Oxeli...

7/5/2023NMPA Issues the Provisions on Drug Standards

7/4/2023CDE Publicizes the List of Reference Formulations for GQCE Studies (72...

7/4/2023CDE Issues the Announcement for Applicability of ICH Guideline M10 Q&A...

7/3/2023NMPA Solicits Comments on the Draft Measures for the Supervision and I...

7/3/2023CDE Issues the Guidelines for Acceptance and Evaluation of APIs (Trial...

6/30/2023NMPA Solicits Comments on the Draft Technical Guidelines for Preparing...

6/29/2023NMPA Launches Nationwide Drug Safety Campaign

6/29/2023NMPA Releases Draft Documents Relating to Drug Package Insert Reform

Page:7/9 Total number of articles:250: [First][<<] [5] [6] [7] [8] [9] [>>] [End]